Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC
Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than weeks. Copenhagen, Feb. 25, 2025 (GLOBE NEWSWIRE) — Gene therapy’s… Read More »Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC